Atamestane

Atamestane

Systematic (IUPAC) name
(8R,9S,10S,13S,14S)-1,10,13-Trimethyl-7,8,9,11,12, 14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione
Clinical data
Legal status	UK: Class C
Identifiers
CAS Registry Number	96301-34-7 N
ATC code	None
PubChem	CID 57050
ChemSpider	51438 Y
UNII	62GA3K28B6 Y
ChEMBL	CHEMBL2105987 N
Chemical data
Formula	C20H26O2
Molecular mass	298.419 g/mol
SMILES O=C\1/C=C(/C)[C@]4(C(=C/1)/CC[C@@H]3[C@@H]4CC[C@@]2(C(=O)CC[C@H]23)C)C
InChI InChI=1S/C20H26O2/c1-12-10-14(21)11-13-4-5-15-16-6-7-18(22)19(16,2)9-8-17(15)20(12,13)3/h10-11,15-17H,4-9H2,1-3H3/t15-,16-,17-,19-,20-/m0/s1  Y Key:PEPMWUSGRKINHX-TXTPUJOMSA-N  Y
N (what is this?)  (verify)

Atamestane is an aromatase inhibitor that is being studied in the treatment of cancer. Atamestane blocks the production of the hormone estrogen in the body.

It is selective.^[1]

References

External links

• Atamestane entry in the public domain NCI Dictionary of Cancer Terms

 This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".